Epidemiology of cardiovascular complications in diabetes mellitus;Epidemiologie des complications cardio-vasculaires du diabete

Diabetes and Metabolism

Volumn 25, Issue SUPPL. 3, 1999, Pages 12-20

  Grimaldi, A ^a   Heurtier, A ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b NONE

Author keywords

Cardiovascular complications; Diabetes mellitus; Epidemiology

Indexed keywords

HEMOGLOBIN A1C; INSULIN; SULFONYLUREA; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ATHEROGENESIS; CONFERENCE PAPER; DIABETES MELLITUS; DRUG EFFICACY; ETHNIC GROUP; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERGLYCEMIA; INSULIN RESISTANCE; MALE; MICROANGIOPATHY; MORTALITY; RISK FACTOR; CARDIOVASCULAR DISEASE; DIABETIC ANGIOPATHY; FEMALE; FORWARD HEART FAILURE; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW;

CARDIAC OUTPUT, LOW; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; HYPERGLYCEMIA; MALE; RISK FACTORS;

EID: 0033041271     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (86)

1. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diiabetes. N Engl J Med, 1993, 329, 977-986.
2. Skyler JS. Diabetic complications : the importance of glucose control. Endocrinology and Metabolism Clinics of North America. Chronic Complications of Diabetes. Edit. M Brownle, GL King. Philadephia, 1996, 25, 243-284.
3. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes, 1994, 43, 960-967.
4. Malmberg K. for the Digami (Diabetes Mellitus Insulin Glucose Infusion in acute Myocardial Infarction) Study Group Prospective randomised study of intensive insulin treatment of long term survival after acute myocardial infarction in ptients with diabetes mellitus. Brit Med J, 1997, 314, 1512-1515.
5. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 1998, 352, 837-853.
6. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes. Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Arch Intern Med, 1997, 157, 181-188.
7. Pirart J. Diabète et complications dégénératives. Présentation d'une étude prospective portant sur 4 400 cas observés entre 1947 et 1973. Diabete & Metabol, 1977, 3, 97-107.
8. Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care, 1995, 18, 258-268.
9. Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med, 1993, 329, 304-309.
10. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus : a randomized prospective 6-year study. Diabetes Res Clin Pract, 1995, 28, 103-117.
11. The Diabetes Control and Complications Trial Research Group. Clustering of long-term complications in families with diabetes in the Diabetes Control and Complications Trial. Diabetes, 1997, 46, 1829-1839.
12. Marre M, Jeunemaitre X, Gallois Y, Rodier M, Chatellier G, Sert C, Dusselier L, Kahal Z, Chaillous L, Halimi S, Muller A, Sackmann H, Bauduceau B, Bled F, Passa P, Alhenc-Gelas F. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes. J Clin Invest, 1997, 99, 1585-1895.
13. The Diabetes Control and Complications Trial Research Group. The absence of a glycemic threshold for the development of long-term complications : the perspective of the Diabetes Control and Complications Trial. Diabetes, 1996, 45, 1289-1298.
14. The Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes, 1995, 44, 968-983.
15. Krolewski AS, Warram JH, Freire MBS. Epidemiology of late diabetic complications : a basis for the development and evaluation of preventive programs. Chronic complications of diabetes. Endocrinology and Metabolism Clinics of North America, 1996, 25, 217-242.
16. Parving HH. Renoprotection in diabetes : genetic and non-genetic risk factors and treatment. Diabetologia, 1998, 41, 745-759.
17. Janka HU, Warram JH, Rand LI, Krolewski AS. Risk factors for progression of background retinopathy in long-standing IDDM. Diabetes, 1989, 38, 460-464.
18. Parving HH, Andersen AR, Midt UM, Hommel E, Mathiesen ER, Svendsen PA. Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Brit Med J, 1987, 294, 1443-1446.
19. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. Br Med J, 1998, 317, 703-713.
20. Chaturvedi N, Sjolie AK, Stephenson JM, Abrahamian H, Keipes M, Castellarin A, Rogulja-Pepeonik Z, Fuler JH, and the EUCLID study Group. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The Lancet, 1998, 351, 28-31.
21. Warram JH, Kopczynski J, Janka HU, Krolewski AS. Epidemiology of non-insulin-dependent diabetes mellitus and its macrovascular complications. Endocrinology and Metabolism Clinics of North America. Chronic Complications of Diabetes. Edit. M Brownlee, GL King. Philadephia, 1996, 26, 165-188.
22. Kannel WB, Mac Gee DL. Diabetes and cardiovascular risk factors : the Framingham study. Circulation, 1979, 59, 8-13.
23. Milan Study on Atherosclerosis and Diabetes (MiSAD) Group. Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic risk factors in non-inulin-dependent diabetes mellitus. Am J Cardiol, 1997, 79, 134-139.
24. Laakso M, Lehto S. Epidemiology of macrovascular disease in diabetes. Diabetes Reviews, 1997, 5, 294-315.
25. Skyler JS. Diabetes Complications : the importance of glucose control. Endocrinology and Metabolism Clinics of North America. Chronic Complications of Diabetes. Edit. M Brownlee, GL King. Philadephia, 1996, 25, 243-254.
26. Beks PJ, Mackaay AJ, De Neeling JND, De Vries H, Bouter LM, Heine RJ. Peripheral arterial disease in relation to glycaemic level in an elderly caucasian population : the Hoorn Study. Diabetologia, 1995, 38, 86-96.
27. Siitonen OI, Niskanen LK, Laakso M, Siitonen JT, Pyörälä K. Lower-extremity amputations in diabetic and nondiabetic patients. Diabetes Care, 1993, 16, 16-20.
28. Gu K, Cowie CC, Harris MI. Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care, 1998, 21, 1138-1145.
29. Laakso M, Rönnemaa T, Lehto S, Puukka P, Kallio V, Pyörälä K. Does NIDDM increase the riskfor coronary heart disease similarly in both low- and high-risk populations ? Diabetologia, 1995, 38, 487-493.
30. Stamler J, Vaccaro O, Neaton JD, Wentworth D. For the Multiple Risk Factor Intervention Trial Research Group. Diabetes, other risk factors, and 12-Yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care, 1993, 16, 434-444.
31. Manson JE, Colditz GA, Stampfer MJ, Willett WC, Krolewski AS, Rosner B, Arky RA, Speizer FE, Hennekens CH. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med, 1991, 151, 1141-1147.
32. Jensen T, Borch-Johnsen K, Kofoed-Enevoldsen A, Deckert T. Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy : incidence and risk factors. Diabetologia, 1987, 30, 144-148.
33. Tuomilehto J, Borch-Johnsen K, Molarius A, Forsen T, Rastenyte D, Sarti C, Reunanen A. Incidence of cardiovascular disease in type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropthy in Finland. Diabetologia, 1998, 41, 784-790.
34. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Bent-Hansen L, Kofoed-Enevoldsen A. Proteinuria, an indicator of malignant angiopathy, in diabetic complications : early diagnosis and treatment. Edit D Andrenai, G Crepaldi, U Di Mario, G Pozza, John Wiley & sons, Chichester, 1987, 257-262.
35. Brownlee M. Glycation products and the pathogenesis of diabetic complications. Diabetes Care, 1992, 15, 1835-1843.
36. Jones SL, Close CF, Mattock MB, Keen H, Viberti GC. Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria. Br Med J, 1989, 298, 487-490.
37. Earle K, Walker J, Hill C, Viberti G. Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy. N Engl J Med, 1992, 326, 673-677.
38. Haffner SM, Stern MP, Kozlowski Gruber MK, Hazuda HP, Mitchell BD, Patterson JK. Microalbuminuria. Potential marker for increased cardiovascular risk factors in nondiabetic subjects? Arteriosclerosis, 1990, 10, 727-731.
39. Howard WJ, Nugent Z, Manley SE, Mann J, Turner RC. UL Prospective Diabetes Study VI. Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biochemical risk factors. Diabetes Res, 1990, 13, 1-11.
40. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the litterature. Arch Intern Med, 1997, 157, 1413-1418.
41. Krolewski AS, Kosinski EJ, Warram JH, Leland S, Busick EJ, Asmal AC, Rand LI, Christlieb AR, Bradley RF, Kahn CR. Magnitude and determinants of coronary artery disease in juvenile-onset insulin-dependent diabetes mellitus. Am J Cardiol, 1987, 59, 750-755.
42. Rossing P, Hougaard P, Borch-Johnsen K, Parving HH. Predictors of mortality in insulin dependent diabetes : 10 year observational follow up study. Br Med J, 1996, 313, 779-784.
43. Nelson RG. Sievers ML, Knowler WC, Swinburn BA, Pettitt DJ, Saad MF, Liebow IM, Howard BV, Bennett PH. Low incidence of fatal coronary heart disease in Pima Indiens despite high prevalence of non-insulin-dependent diabetes. Circulation, 1990, 81, 987-995.
44. U.K. Prospective Diabetes Study Group. Ethnicity and cardiovascular disease. The incidence of myocardial infarction in white, South Asian, and Afro-Caribbean patients with type 2 diabetes (U.K. Prospective Diabetes Study 32). Diabetes Care, 1998, 21, 1271-1277.
45. Chaturvedi N, Mac Keigue PMM, Marmot MG. Relationship of glucose intolerance to coronary risk in Afro-Caribbeans compared with Europeans. Diabetologia, 1994, 37, 765-772.
46. Knight TM, Smith Z, Whittles A, Sahota P, Lockton JA, Hogg G, Bedford A, Toop M, Kernohan Eem, Baker MR. Insulin resistance, diabetes, and risk markers for ischaemic heart disease in Asian men and non-Asian men in Bradford. Br Heart J, 1992, 67, 343-350.
47. Howard BV. Diabetes and plasma lipoproteins in native americans. Studies of the Pima Indiens. Diabetes Care, 1993, 16, 284-291.
48. Capron L. Athérosclérose et complications cardio-vasculaires du diabète. Ann Endocrinol, 1996, 57, 161-165.
49. Everhart JE, Pttitt DJ, Knowler WC, Rose FA, Bennett PH. Medial arterial calcification and its association with mortality and complications of diabetes. Diabetologia, 1988, 31, 16-23.
50. Lehto S, Niskanen L, Sihonen M, Rönnemaa T, Laakso M. Medical artery calcification. A neglected harbinher of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscl Thromb Vasc Biol, 1996, 16, 978-983.
51. Rossing P, Hougaard P, Borch-Johnsen K, Parving HH. Predictors of mortality in insulin-dependent diabetes : 10 year observational follow up study. Br Med J, 1996, 313, 779-784.
52. Turner RC, Millns H, Neil HAW, Statton IM, Manley SE, Holman RR. For the United Kingdom Prospective Diabetes Study Group. Br Med J, 1998, 316, 823-828.
53. Alberti KGMM. Lipids and diabetes : a fatal combination? Diabetic Med, 1998, 15, 359.
54. U.K. Prospective Diabetes Study Group. U.K. prospective diabetes study 27. Plasma lipids and lipoproteins at diagnosis of NIDDM by age and sex. Diabetes Care, 1997, 20, 1683-1687.
55. The DCCT Research Group. Lipid and lipoprotein levels in patients with IDDM. Diabetes Control and Complications Trial experience. Diabetes Care, 1992, 15, 886-894.
56. Matsumoto T, Ohashi Y, Yamada N, Kiruchi M. Coronary heart disease mortality is actually low in diabetic Japanese by direct comparison with the Joslin cohort. Diabetes Care, 1994, 17, 1062-1064.
57. Kawate R, Yamakido M, Nishimoto Y, Bennett PH, Hamman RF, Knowler WC. Diabetes mellitus and its vascular complications in Japanese migrants on the Islandof Hawaï. Diabetes Care, 1979, 2, 161-170.
58. Niskanen L, Turpeinen A, Penttila I, Uusitupa MIJ. Hyperglycemia and compositional lipoprotéin abnormalities as predictors of cardiovascular mortality in type 2 diabetes. A 15-year follow-up from the time of diagnosis. Diabetes Care, 1998, 21, 1861-1869.
59. Griffin BA. Low-density lipoprotein heterogeneity. In Bailliere's clinical endocrinology and metabolism. International practice and research. Dyslpidemia. Edit. DJ Betteridge, 1995, 9, 687-703.
60. Semenkovich CF, Heinecke JW. The mystery of diabetes and atherosclerosis... Time for a new plot. Diabetes, 1997, 46, 327-334.
61. Jokl R, Colwell JA. Arterial thrombosis and atherosclerosis in diabetes. Diabetes Rev, 1997, 5, 316-331.
62. Hsueh WA, Quinones MJ, Creager MA. Endothelium in insulin resistance and diabetes. Diabetes Rev, 1997, 5, 343-353.
63. Paolisso G, Howard BV. Role of non-esterified fatty acids in the pathogenesis of type 2 diabetes mellitus. Diabetic Med, 1998, 15, 360-366.
64. Chen YDI, Reaven GM. Insulin resistance and atherosclerosis. Diabetes Rev, 1997, 5, 331-343.
65. Wei M, Gaskill SP, Haffner SM, Stern MP. The San Antonio Heart Study. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. Diabetes Care, 1998, 21, 1167-1172.
66. Folsom AR, Liao F, Szklo M, Smith R, Stevens J, Eckfeldt JH. A prospective study of coronary heart disease in relation to fasting insulin, glucoe, and diabetes. The Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care, 1997, 20, 935-942.
67. Park S, Barrett-Connor E, Wingard DL, Shan J, Edelstein S. GHb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucoe in women without diabetes. The Rando Bernardo Study. Diabetes Care, 1996, 19, 450-456.
68. Singer DE, Nathan DM, Anderson KM, Wilson PW, Evans JC. Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes, 1992, 41, 202-208.
69. Balkau B, Shipley M, Jarrett RJ, Pyörälä K, Pyörälä M, Forhan A, Eschwege E. High blood glucose concentation is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care, 1998, 21, 360-367.
70. Haaffner SM. Impaired glucose tolerance - is it relevant for cardiovascular disease? Diabetologia, 1997, 40, 138-140.
71. Meigs JB, D'agostino RB, Wilson PWF, Cupples A, Nathan DM, Snger DE. Risk variable clustering in the insulin resistance syndrome. Diabetes, 1997, 46, 1594-1600.
72. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes, 1992, 41, 715-722.
73. Turner RC, Millns H, Holman RR. Coronary heart disease and risk factors in NIDDM. Experience from the United Kingdom Prospective Diabetes Study. Diabetologia, 1997, 40, 121-122.
74. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes, 1994, 43, 960-967.
75. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronry heart disease start ticking before the onset of clinical diabetes? JAMA, 1990, 263, 2893-2898.
76. University Group Diabetes Program. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. Diabetes, 1976, 25, 1129-1153.
77. The Diabetes Control and Complications Trial (DCCT) Research Group. Effect of intensive diabetes management on macrovascular events and risk factors in the diabetes control and complications trial. Am J Cardiol, 1995, 75, 894-903.
78. United Kingdom Prospective Diabetes Study Group. Insulin led to lower glucose levels, less combination therapy, and more weight gain in type 2 diabetes mellitus. Ann Intern Med, 1998, 128, 165-175.
79. Bloomgarden ZT. Topics in cardiovascular disease and diabetes. Diabetes Care, 1997, 20, 1624-1627.
80. Sinha A, Formica C, Tsalamandris C, Panagiotopoulos S, Hendrich E, De Luise M, Seeman E, Jerums G. Effects of insulin on body composition in patients with insulin-dependent and non-insulin-dependent diabetes. Diabetic Med, 1996, 13, 40-46.
81. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet, 1998, 352, 854-865.
82. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in non-diabetic subjects with and without prior myocardial infarction. N Engl J Med, 1998, 339, 229-234.
83. Eschwege E, Balkau B, Fontbonne A. The epidemiology of coronary heart disease in glucose-intolerant and diabetic subjects. J Intern Med, 1994, 236, 5-11.
84. Bourdel-Marchasson I, Dubroca B, Decamps A, Richard-Harston S, Emeriau JP, Dartigues JF. Five-year mortality in elderly frebnh subjects from the PAQUID epidemiological survey : the burden of diabetes. Diabet Med, 1998, 15, 830-835.
85. Who Monica Project. Geographical variation in the major risk factors of coronary heart disease in men and women aged 35-64 years. The Who Monica Project. World Health Stat Q, 1988, 41, 115-140.
86. Yudkin JS. How can we best prolong life? Benefits of coronary risk factor reduction in non-diabetic and diabetic subjects. Br Med J, 1993, 306, 1313-1318.